Latest California Healthline Stories
Severe Sleep Apnea Diagnosis Panics Reporter Until He Finds a Simple, No-Cost Solution
An industry has grown up around sleep apnea, stirring concerns about overdiagnosis and overtreatment.
Pharma-Funded FDA Gets Drugs Out Faster, But Some Work Only ‘Marginally’ and Most Are Pricey
Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.
KHN’s ‘What the Health?’: On Government Spending, Congress Decides Not to Decide
Congress has once again decided not to decide how to fund the federal government in time for the start of the fiscal year, racing toward a midnight Sept. 30 deadline to pass a stopgap bill that would keep the lights on for two more months. However, it does appear the FDA’s program that gets drugmakers to help fund some of the agency’s review staff will be renewed in time to stop pink slips from being sent. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Victoria Knight of Axios join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews filmmaker Cynthia Lowen, whose new documentary, “Battleground,” explores how anti-abortion forces played the long game to overturn Roe v. Wade.
Few Places Have More Medical Debt Than Dallas-Fort Worth, but Hospitals There Are Thriving
Some hospitals notch big profits while patients are pushed into debt by skyrocketing medical prices and high deductibles, a KHN analysis finds.
‘American Diagnosis’: When Indigenous People Move to Cities, Health Care Funds Don’t Follow
When Indigenous people started moving to cities in large numbers after World War II, many found hardship and discrimination there … but not the health care they were entitled to. Episode 12, the season finale, explores the efforts of urban Indian health providers to close those gaps by providing affordable, culturally competent care.
Britain’s Hard Lessons From Handing Elder Care Over to Private Equity
Four Seasons Health Care collapsed after years of private equity investors rolling in one after another to buy its business, sell its real estate, and at times wrest multimillion-dollar profits from it through complex debt schemes. The deal-making failed to account for the true cost of senior care.
Hemp-Derived Delta-8 Skirts Marijuana Laws and Raises Health Concerns
A cannabis product called delta-8 was made legal when the 2018 Farm Bill legalized hemp. But unlike its cousin CBD, delta-8 has psychoactive properties. And the FDA warns it has “serious health risks.” The agency has received more than 100 reports of bad reactions among people who consumed it.
KHN’s ‘What the Health?’: Biden Declares the Pandemic ‘Over’
President Joe Biden, in an interview with CBS’ “60 Minutes,” declared the covid-19 pandemic “over,” stoking confusion for members of his administration trying to persuade Congress to provide more funding to fight the virus and the public to get the latest boosters. Meanwhile, concerns about a return of medical inflation is helping boost insurance premiums even as private companies race to get their piece of the health pie. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Lauren Weber of KHN join KHN’s Julie Rovner to discuss these issues and more. Also, for extra credit, the panelists suggest their favorite health policy stories they think you should read, too.
Shift in Child Hospice Care Is a Lifeline for Parents Seeking a Measure of Comfort and Hope
Terminally ill children, unlike adults, can get hospice services while continuing to receive life-extending or curative care. More than a decade after the inception of the federal policy, it is widely credited with improving the quality of life for ailing children and their families, even as some parents find themselves in a painful stasis.
Death Is Anything but a Dying Business as Private Equity Cashes In
Investors are banking on increased demand in death care services as 73 million baby boomers near the end of their lives.